T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis
出版年份 2023 全文链接
标题
T cell-derived interleukin-22 drives the expression of CD155 by cancer cells to suppress NK cell function and promote metastasis
作者
关键词
-
出版物
IMMUNITY
Volume 56, Issue 1, Pages 143-161.e11
出版商
Elsevier BV
发表日期
2023-01-11
DOI
10.1016/j.immuni.2022.12.010
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tissue resident iNKT17 cells facilitate cancer cell extravasation in liver metastasis via interleukin-22
- (2023) Anastasios D. Giannou et al. IMMUNITY
- Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses
- (2022) Karl L. Banta et al. IMMUNITY
- CD226: a potent driver of antitumor immunity that needs to be maintained
- (2021) Jiacheng Bi Cellular & Molecular Immunology
- The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based design
- (2021) Robert A. Saxton et al. IMMUNITY
- Coenzyme A fuels T cell anti-tumor immunity
- (2021) Michael St. Paul et al. Cell Metabolism
- Tumor Immunology and Tumor Evolution: Intertwined Histories
- (2020) Jérôme Galon et al. IMMUNITY
- CD155: A Multi-Functional Molecule in Tumor Progression
- (2020) Rosa Molfetta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- SciPy 1.0: fundamental algorithms for scientific computing in Python
- (2020) Pauli Virtanen et al. NATURE METHODS
- Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics
- (2020) Sadal Refae et al. Scientific Reports
- IL6 Induces an IL22+ CD8+ T-cell Subset with Potent Antitumor Function
- (2020) Michael St. Paul et al. Cancer Immunology Research
- Tumor CD155 expression is associated with resistance to anti-PD1 immunotherapy in metastatic melanoma
- (2020) Ailin Lepletier et al. CLINICAL CANCER RESEARCH
- TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer
- (2020) Laura Garcia Perez et al. Nature Communications
- CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
- (2020) Hyung-seung Jin et al. Cancer Immunology Research
- IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma
- (2020) Joe-Marc Chauvin et al. CLINICAL CANCER RESEARCH
- IL22BP Mediates the Anti-Tumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans
- (2020) Jan Kempski et al. GASTROENTEROLOGY
- Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
- (2020) Marianne Weulersse et al. IMMUNITY
- CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells
- (2020) Matthias Braun et al. IMMUNITY
- Array programming with NumPy
- (2020) Charles R. Harris et al. NATURE
- Interleukin-22 protects intestinal stem cells against genotoxic stress
- (2019) Konrad Gronke et al. NATURE
- Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
- (2019) Chengcheng Jin et al. CELL
- IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation
- (2019) Wenjun Ouyang et al. IMMUNITY
- Determining cell type abundance and expression from bulk tissues with digital cytometry
- (2019) Aaron M. Newman et al. NATURE BIOTECHNOLOGY
- CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing
- (2019) Kornel Labun et al. NUCLEIC ACIDS RESEARCH
- CD155 expression and its prognostic value in postoperative patients with breast cancer
- (2019) Hongmei Yong et al. BIOMEDICINE & PHARMACOTHERAPY
- High expression of soluble CD155 in estrogen receptor-negative breast cancer
- (2019) Akiko Iguchi-Manaka et al. Breast Cancer
- CD155 expression in human breast cancer: Clinical significance and relevance to natural killer cell infiltration
- (2019) Hana Triki et al. LIFE SCIENCES
- Intratumoral IL22‐producing cells define immunoevasive subtype muscle‐invasive bladder cancer with poor prognosis and superior nivolumab responses
- (2019) Han Zeng et al. INTERNATIONAL JOURNAL OF CANCER
- CD155 contributes to the mesenchymal phenotype of triple‐negative breast cancer
- (2019) Qianqian Zheng et al. CANCER SCIENCE
- Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice
- (2019) Mirna Perusina Lanfranca et al. GASTROENTEROLOGY
- Interleukin‐22 promotes development of malignant lesions in a mouse model of spontaneous breast cancer
- (2019) Gajendra K. Katara et al. Molecular Oncology
- Tumor intrinsic and extrinsic immune functions of CD155
- (2019) Jake. S. O’Donnell et al. SEMINARS IN CANCER BIOLOGY
- Analysis of Th22, Th17 and CD4 + cells co-producing IL-17/IL-22 at different stages of human colon cancer
- (2018) Hassan Doulabi et al. BIOMEDICINE & PHARMACOTHERAPY
- IL-22RA1/ STAT3 signaling promotes stemness and tumorigenicity in pancreatic cancer
- (2018) Weizhi He et al. CANCER RESEARCH
- A catch-22: Interleukin-22 and cancer
- (2018) Pedro Hernandez et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oxysterol Sensing through the Receptor GPR183 Promotes the Lymphoid-Tissue-Inducing Function of Innate Lymphoid Cells and Colonic Inflammation
- (2018) Johanna Emgård et al. IMMUNITY
- Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study
- (2018) Franck Pagès et al. LANCET
- Targeting interleukin-22 for cancer therapy
- (2018) Anamarija Markota et al. Human Vaccines & Immunotherapeutics
- IL22 Promotes Kras -Mutant Lung Cancer by Induction of a Protumor Immune Response and Protection of Stemness Properties
- (2018) Nasim Khosravi et al. Cancer Immunology Research
- Distribution and Interaction of Murine Pulmonary Phagocytes in the Naive and Allergic Lung
- (2018) Franziska M. Hoffmann et al. Frontiers in Immunology
- Identification of cancer subtypes from single-cell RNA-seq data using a consensus clustering method
- (2018) Yanglan Gan et al. BMC Medical Genomics
- Targeting PVR (CD155) and its receptors in anti-tumor therapy
- (2018) Paola Kučan Brlić et al. Cellular & Molecular Immunology
- A Protective Function of IL-22BP in Ischemia Reperfusion and Acetaminophen-Induced Liver Injury
- (2017) Dörte Kleinschmidt et al. JOURNAL OF IMMUNOLOGY
- Cancer cells induce interleukin-22 production from memory CD4+T cells via interleukin-1 to promote tumor growth
- (2017) Cornelia Voigt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A BaSiC tool for background and shading correction of optical microscopy images
- (2017) Tingying Peng et al. Nature Communications
- IL-22 promotes the progression of breast cancer through regulating HOXB-AS5
- (2017) Jiang Rui et al. Oncotarget
- Interleukin-22 is elevated in lavage from patients with lung cancer and other pulmonary diseases
- (2016) Amanda Tufman et al. BMC CANCER
- Interleukin-22 receptor is overexpressed in nonsmall cell lung cancer and portends a poor prognosis
- (2016) Antoine Guillon et al. EUROPEAN RESPIRATORY JOURNAL
- Chromosomal localisation of the CD4cre transgene in B6·Cg-Tg(Cd4-cre)1Cwi mice
- (2016) Kerstin Westendorf et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways
- (2016) Yi Bi et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Metastatic colonization by circulating tumour cells
- (2016) Joan Massagué et al. NATURE
- Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
- (2016) Malte Mohme et al. Nature Reviews Clinical Oncology
- Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
- (2016) S. J. Blake et al. Cancer Discovery
- Interleukin-22: Immunobiology and Pathology
- (2015) Jarrod A. Dudakov et al. Annual Review of Immunology
- Nitric oxide donors increase PVR/CD155 DNAM-1 ligand expression in multiple myeloma cells: role of DNA damage response activation
- (2015) Cinzia Fionda et al. BMC CANCER
- Intra-tumoral IFN- -producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer
- (2015) E. Niccolai et al. CLINICAL SCIENCE
- Rationally engineered Cas9 nucleases with improved specificity
- (2015) I. M. Slaymaker et al. SCIENCE
- IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling
- (2014) H Fukui et al. BRITISH JOURNAL OF CANCER
- Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation
- (2014) K. Kim et al. CARCINOGENESIS
- iDISCO: A Simple, Rapid Method to Immunolabel Large Tissue Samples for Volume Imaging
- (2014) Nicolas Renier et al. CELL
- The role of the IL-22/IL-22R1 axis in cancer
- (2014) Chrissie Lim et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IL-22+CD4+ T Cells Promote Colorectal Cancer Stemness via STAT3 Transcription Factor Activation and Induction of the Methyltransferase DOT1L
- (2014) Ilona Kryczek et al. IMMUNITY
- The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
- (2014) Christopher J Chan et al. NATURE IMMUNOLOGY
- Increased Intratumoral Interleukin 22 Levels and Frequencies of Interleukin 22–Producing CD4+ T Cells Correlate With Pancreatic Cancer Progression
- (2014) Xuejun Xu et al. PANCREAS
- KLRG1+natural killer cells protect against pulmonary metastatic disease by immunosurveillance
- (2014) Philipp Renner et al. OncoImmunology
- High Expression of Interleukin-22 and Its Receptor Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma
- (2013) Zhang Wen et al. ANNALS OF SURGICAL ONCOLOGY
- IL-22 is related to development of human colon cancer by activation of STAT3
- (2013) Runqiu Jiang et al. BMC CANCER
- Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
- (2013) F. Ann Ran et al. CELL
- Interleukin-22 serum levels are a negative prognostic indicator in patients with hepatocellular carcinoma
- (2013) Oliver Waidmann et al. HEPATOLOGY
- Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells
- (2013) Sebastian Kobold et al. Journal of Thoracic Oncology
- Therapeutic opportunities of the IL-22–IL-22R1 system
- (2013) Robert Sabat et al. NATURE REVIEWS DRUG DISCOVERY
- IFNα converts IL-22 into a cytokine efficiently activating STAT1 and its downstream targets
- (2012) Malte Bachmann et al. BIOCHEMICAL PHARMACOLOGY
- Increased intratumoral IL-22-producing CD4+ T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival
- (2012) Yuan Zhuang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade
- (2012) Anupam Mitra et al. CYTOKINE
- Increased Circulating Th22 and Th17 Cells are Associated with Tumor Progression and Patient Survival in Human Gastric Cancer
- (2012) Tao Liu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
- (2012) Samuel Huber et al. NATURE
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: relevance for NK-T cell interaction
- (2011) M. Ardolino et al. BLOOD
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
- (2011) Runqiu Jiang et al. HEPATOLOGY
- Control of TH17 cells occurs in the small intestine
- (2011) Enric Esplugues et al. NATURE
- A mouse knockout library for secreted and transmembrane proteins
- (2010) Tracy Tang et al. NATURE BIOTECHNOLOGY
- Globally optimal stitching of tiled 3D microscopic image acquisitions
- (2009) S. Preibisch et al. BIOINFORMATICS
- DNAM-1/CD155 Interactions Promote Cytokine and NK Cell-Mediated Suppression of Poorly Immunogenic Melanoma Metastases
- (2009) C. J. Chan et al. JOURNAL OF IMMUNOLOGY
- Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency
- (2009) Akitsu Hotta et al. NATURE METHODS
- ATM-ATR-dependent up-regulation of DNAM-1 and NKG2D ligands on multiple myeloma cells by therapeutic agents results in enhanced NK-cell susceptibility and is associated with a senescent phenotype
- (2008) A. Soriani et al. BLOOD
- Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel Disease
- (2008) Lauren A. Zenewicz et al. IMMUNITY
- Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
- (2008) Yan Zheng et al. NATURE MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started